Latest News
World Vaccine Congress Europe 2026
When 19-21 October 2026Location Amsterdam, NetherlandsJoin P95 Julius Clinical at World Vaccine Congress 2026 in Amsterdam from October 19-21, 2026 Stop by booth #310 to meet our clinical and real-world evidence experts to discover how we support vaccine and...
Research at the Speed of Outbreak
No licensed vaccine or therapeutic exists for the Bundibugyo Ebola strain. Drawing on five landmark outbreak trials, this white paper outlines the clinical research and vaccine development strategies needed to close the gap, and what sponsors, CROs, and regulators should do now.
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
P95 and Julius Clinical merge forming a 500+ person global CRO spanning 25+ countries with operations in North America, Europe, Africa, Latin America, and Asia-Pacific
Running Vaccine Trials in Africa: What You Need to Know
Learn about about what it truly takes to run vaccine trials in Africa today in this podcast episode
World Vaccine Congress Europe 2026
When 19-21 October 2026Location Amsterdam, NetherlandsJoin P95 Julius Clinical at World Vaccine Congress 2026 in Amsterdam from October 19-21, 2026 Stop by booth #310 to meet our clinical and real-world evidence experts to discover how we support vaccine and...
Poster Presentation: Understanding severe respiratory infections in medically vulnerable adults across Europe: New insights from the id.DRIVE Network
Presented at the European Respiratory Society (ERS) International Congress 2026, this poster explores the demographic and clinical characteristics, treatment patterns, and outcomes of adults hospitalized with severe acute respiratory infection (SARI) across Europe....
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI and More Representative Research
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI & More Representative Research
Latest Press
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
P95 and Julius Clinical merge forming a 500+ person global CRO spanning 25+ countries with operations in North America, Europe, Africa, Latin America, and Asia-Pacific
P95 Partners in South Africa’s Historic Cholera Vaccine Clinical Trial (OcV-S)
P95 is proud to serve as the selected CRO for the cholera vaccine clinical trial of OCV-S, South Africa’s first fully homegrown vaccine
P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence
P95 and Julius Clinical merge forming a 500+ person global CRO spanning 25+ countries with operations in North America, Europe, Africa, Latin America, and Asia-Pacific
P95 and LatinaBA enter a strategic partnership to propel vaccine research in Latin America
P95 and LatinaBA are pleased to announce their strategic partnership, aimed at propelling vaccine and infectious disease research in Latin America.
P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services
P95, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, is excited to announce the acquisition of Assign DMB.
P95 Company News
View All
Expanding with Purpose: P95 Opens New Offices in Ghana and Kenya to Strengthen Vaccine Research Across Africa
In April 2025, P95 proudly opened two new offices on the African continent, in Kenya and Ghana, reinforcing regional impact and collaboration
P95 Transforming Exercise into Charitable Impact
At P95, we believe in the power of movement – not just as a means to personal health, but as a catalyst for global change. Our Strava group, an initiative that promotes health and fitness within the team, has successfully translated the time logged over the last year into substantial donations for three charities that make a real difference.
Laurence De Moerlooze Joins P95 as Chief Medical Officer
P95 BV, an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief Medical Officer (CMO).
Celebrating P95’s Anniversary: From our Humble Beginnings to a Global Full-Service CRO
As we approach our 13th anniversary on June 16, we pause to celebrate important milestones and extend our deepest gratitude to our staff, partners and clients who have been part of our growth journey!
P95’s Journey From Epidemiology Consulting to Comprehensive CRO
In a recent interview for Ampersand Capital Partners, our CEO, Thomas Verstraeten, and Chairman, Benoit Bouche shared pivotal insights into P95’s growth from an epidemiology consulting into a global comprehensive Contract Research Organization (CRO).
Almost one year from P95’s partnership with Ampersand Capital Partners, the article dives deeper into P95’s expanding global reach, client-focused capabilities, and commitment to global health that bring our company to the forefront.
Events News
View All
World Vaccine Congress Europe 2026
When 19-21 October 2026Location Amsterdam, NetherlandsJoin P95 Julius Clinical at World Vaccine Congress 2026 in...
Poster Presentation: Understanding severe respiratory infections in medically vulnerable adults across Europe: New insights from the id.DRIVE Network
Presented at the European Respiratory Society (ERS) International Congress 2026, this poster explores the demographic and clinical characteristics, treatment patterns, and outcomes of adults hospitalized with severe acute respiratory infection (SARI) across Europe....
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI and More Representative Research
ISPE 2026 Takeaways: Real-World Evidence, Methodological Precision, AI & More Representative Research
Vaccine Clinical Development Plan Webinar: Drafting a CDP
The Vaccine Clinical Development Plan Webinar: Drafting a CDP is part of The Council for the Promotion of International Vaccine Cooperation (CPIVC) webinar series and features P95 speakers sharing practical guidance for sponsors and clinical leaders who need a clear,...
How to Design Phase I Vaccine Studies in Europe Webinar
The How to Design Phase I Vaccine Studies in Europe Webinar is a focused session for sponsors and biotech leaders preparing for clinical entry in a complex and rapidly evolving regulatory landscape. With the right design, early-phase trials not only build the evidence...
P95 is a full-service Contract Research Organization (CRO) specializing in clinical trials, epidemiology, and real-world evidence, for vaccines and infectious diseases.